Search Results for: coronavirus

Open the calendar Use the arrow keys to select a date

Can’t find what you’re looking for? Visit our FAQ page.

505 results
  1. These are the most popular Science News stories of 2022

    Science News drew over 13 million visitors to our website this year. Here’s a recap of the most-read news stories and long reads of 2022.

    By
  2. Health & Medicine

    Merck’s COVID-19 pill may soon be here. How well will it work?

    Once hailed as a potential game changer, more complete data now reveal drawbacks of Merck’s antiviral COVID-19 pill, molnupiravir.

    By
  3. Health & Medicine

    A new antiviral pill cuts COVID-19 hospitalization and death rates

    Merck says its drug, molnupiravir, stops viral replication and can be taken right after a COVID-19 diagnosis.

    By
  4. Health & Medicine

    What experts told me to do after my positive COVID-19 at-home test

    Rapid at-home tests mean many COVID-19 cases go unreported, but they’re a great tool for deciding when to leave isolation. I found that out firsthand.

    By
  5. The triumph and fallibility of science in a historic year

    Editor in chief Nancy Shute discusses the last year in science, including lessons we've learned about COVID-19, human evolution and amazing animal feats.

    By
  6. Health & Medicine

    An anime convention in November was not an omicron superspreader event

    Vaccines, ventilation and other safety measures probably prevented the variant’s spread at Anime NYC, reports suggest.

    By
  7. Health & Medicine

    4 answers to key questions about the monkeypox outbreak

    Monkeypox has cropped up around the world, but it doesn’t spread easily like the coronavirus and most people probably don’t need to be concerned.

    By
  8. Health & Medicine

    In 2021, COVID-19 vaccines were put to the test. Here’s what we learned

    Vaccines can’t single-handedly end the pandemic, but they are still essential in the fight against the coronavirus.

    By
  9. Health & Medicine

    The CDC recommends mRNA COVID-19 vaccines over J&J’s, citing fewer risks

    Pfizer’s and Moderna's vaccines are more effective and cause fewer serious side effects than Johnson & Johnson’s jab, new data show.

    By
  10. Health & Medicine

    New studies hint that the coronavirus may be evolving to become more airborne

    More coronavirus RNA is in fine aerosols than in larger droplets, but masks can reduce the amount of virus in the air.

    By
  11. Health & Medicine

    The first known monkeypox infection in a pet dog hints at spillover risk

    A person passed monkeypox to a dog. Other animals might be next, allowing the virus to set up shop outside of Africa for the first time.

    By
  12. Science & Society

    ‘Virology’ ponders society’s relationship with viruses

    In a collection of wide-ranging essays, microbiologist Joseph Osmundson reflects on the COVID-19 pandemic and calls for “a new rhetoric of care.”

    By